About

Coronary artery disease (CAD) is one of the most common causes of death worldwide. It is responsible for one-third of deaths in people over 35 years old, with the percentage reaching close to 50% (according to some estimates) in western countries.

The existing treatment is medical, surgical or a combination of both depending on the extent, severity and clinical presentation of CAD & .There has been significant progress made in developing novel strategies for patients suffering from CAD and its associated complications. These strategies have ranged from drugs to robotic surgery to nanotechnology.

Articles

Relationship Between VEGF-C Levels and Mortality in Patients with Peripheral Artery Disease

Citation:

European Cardiology Review 2018;13(2):123.

Characteristics of Lipid Profile of LPL Deficiency in Japan – Comparison with Non-LPL Deficiency

Citation:

European Cardiology Review 2018;13(2):132.

Anticoagulation in Patients with Ischaemic Heart Disease and Peripheral Arterial Disease: Clinical Implications of COMPASS study

Citation:

European Cardiology Review 2018;13(2):115–8.

New Advances in the Management of Refractory Angina Pectoris

Citation:

European Cardiology Review 2018;13(1):70–9.